Literature DB >> 7662647

In defence of goniotomy.

I Russell-Eggitt.   

Abstract

Mesh:

Year:  1995        PMID: 7662647      PMCID: PMC505210          DOI: 10.1136/bjo.79.7.709-a

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Trabeculectomy combined with beta irradiation for congenital glaucoma.

Authors:  M H Miller; N S Rice
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

2.  Primary trabeculectomy in congenital glaucoma.

Authors:  J P Burke; R Bowell
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

3.  Combined trabeculotomy-trabeculectomy for congenital glaucoma.

Authors:  G O'Connor
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

4.  Relapse following goniotomy for congenital glaucoma due to trabecular dysgenesis.

Authors:  I M Russell-Eggitt; N S Rice; B Jay; R K Wyse
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

5.  Combined trabeculotomy-trabeculectomy compared with primary trabeculectomy for congenital glaucoma.

Authors:  M J Elder
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

6.  Anatomical classification of the developmental glaucomas.

Authors:  H D Hoskins; R N Shaffer; J Hetherington
Journal:  Arch Ophthalmol       Date:  1984-09
  6 in total
  3 in total

1.  Medical and surgical outcomes in childhood glaucoma: a population-based study.

Authors:  Elisabeth P Aponte; Nancy Diehl; Brian G Mohney
Journal:  J AAPOS       Date:  2011-06-11       Impact factor: 1.220

2.  Prognosis of primary ab externo surgery for primary congenital glaucoma.

Authors:  T S Dietlein; P C Jacobi; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

3.  Long-term follow up of primary trabeculectomy for infantile glaucoma.

Authors:  T Fulcher; J Chan; B Lanigan; R Bowell; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.